Atria Wealth Solutions Inc. increased its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 24.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 33,456 shares of the company’s stock after acquiring an additional 6,604 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Clorox were worth $5,434,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Insight Folios Inc increased its position in Clorox by 3.0% during the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after acquiring an additional 63 shares during the period. HCR Wealth Advisors increased its holdings in Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after buying an additional 68 shares during the period. Empower Advisory Group LLC increased its holdings in Clorox by 4.5% in the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after buying an additional 78 shares during the period. Aviance Capital Partners LLC increased its holdings in Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after buying an additional 80 shares during the period. Finally, Lindbrook Capital LLC increased its holdings in Clorox by 9.9% in the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after buying an additional 88 shares during the period. Institutional investors own 78.53% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have issued reports on CLX. Barclays boosted their price target on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. DA Davidson lowered their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Finally, Wells Fargo & Company boosted their target price on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Clorox has an average rating of “Hold” and a consensus target price of $158.21.
Clorox Stock Up 1.8 %
Shares of NYSE CLX opened at $150.93 on Thursday. The firm’s 50-day simple moving average is $158.38 and its 200 day simple moving average is $159.74. The company has a market cap of $18.68 billion, a price-to-earnings ratio of 41.24, a price-to-earnings-growth ratio of 2.53 and a beta of 0.42. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business posted $2.16 EPS. On average, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- What Makes a Stock a Good Dividend Stock?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is diluted earnings per share (Diluted EPS)?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.